Oxford University Press

SHERPA: Unknown

People

  1. Tuttle
    Tuttle
  2. Breitbart
    Breitbart
  3. Brennan
    Brennan
  4. Saltz
    Saltz
  5. Fagin
    Fagin
  6. Ghossein
    Ghossein
  7. Motzer
    Motzer
  8. Sklar
    Sklar
  9. Massie
    Massie
  10. Postow
    Postow

Groups

  1. Department of Medicine (291)
  2. Solid Tumor Oncology Division (197)
  3. Survivorship Research (153)
  4. Surgery (151)
  5. Population Sciences Research Program (141)
  6. Division of Subspecialty Medicine (106)
  7. Psychiatry and Behavioral Sciences, Department of (94)
  8. Psychiatry Service (82)
  9. Center for Pancreatic Cancer Research (70)
  10. GSK Faculty (64)
Search Within
Formats
  1. Journal Article (489)
  2. Book Section (166)
  3. Review (25)
  4. Meeting Abstract (24)
  5. Editorial (12)
  6. Book Whole (11)
  7. Conference Paper (5)
  8. Correspondence (5)
  9. Research Letter (3)
  10. Guidelines (1)
  11. Miscellaneous (1)
Groups
  1. Department of Medicine (291)
  2. Solid Tumor Oncology Division (197)
  3. Survivorship Research (153)
  4. Surgery (151)
  5. Population Sciences Research Program (141)
  6. Division of Subspecialty Medicine (106)

More Groups

People
  1. Jimmie Holland (72)
  2. Julia Rowland (62)
  3. Robert Tuttle (34)
  4. William Breitbart (31)
  5. Mario Lacouture (17)
  6. Leonard Saltz (16)

More People

Years
  1. 2025 (22)
  2. 2024 (43)
  3. 2023 (39)
  4. 2022 (29)
  5. 2021 (37)
  6. 2020 (31)

More Years

Publications
  1. The Oncologist (291)
  2. Journal of Clinical Endocrinology and Metabolism (106)
  3. British Journal of Surgery (88)
  4. Handbook of Psychooncology: Psychological Care of the Patient with Cancer (62)
  5. Psycho-Oncology. 2nd ed (25)
  6. Diseases of the Esophagus (21)

More Publications

Results (742)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combined RAF and MEK inhibition to treat activated non-V600 BRAF-altered advanced cancers
    Journal Article

    Rustgi, N.; Maria, A.; Toumbacaris, N.; Zhao, H.; Kargus, K.; Bryant, M.; Waksmundzki, A.; Aricescu, I.; Lefkowitz, R. A.; Li, B. T.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Characterization and management of adverse reactions in patients with advanced endometrial cancer receiving lenvatinib plus pembrolizumab
    Journal Article

    Colombo, N.; Lorusso, D.; Monk, B. J.; Slomovitz, B.; Hasegawa, K.; Nogueira-Rodrigues, A.; Zale, M.; Okpara, C. E.; Barresi, G.; McKenzie, J.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • The weighted toxicity score: Confirmation of a simple metric to communicate toxicity in randomized trials of systemic cancer therapy
    Journal Article

    Jordan, J.; Maki, R. G.
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Prevalence of enteric infections in patients on immune checkpoint inhibitors and impact on management and outcomes
    Journal Article

    Magahis, P. T.; Satish, D.; Babady, N. E.; Kamboj, M.; Postow, M. A.; Laszkowska, M.; Faleck, D. M.
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Simultaneous posterior vaginal and perineal reconstruction using gluteal fasciocutaneous flaps following pelvic exenteration with sacrectomy
    Research Letter

    Pappou, E.; Ben-Yaakov, A.; Jiménez-Rodríguez, R. M.; Garcia-Aguilar, J.
    British Journal of Surgery (2024)

    Fulltext@MSK | Save
  • Exocrine pancreatic insufficiency induced by immune checkpoint inhibitors
    Journal Article

    Satish, D.; Lin, I. H.; Flory, J.; Gerdes, H.; Postow, M. A.; Faleck, D. M.
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Phase Ib/II study of the efficacy and safety of binimetinib (MEK162) plus panitumumab for mutant or wild-type RAS metastatic colorectal cancer
    Journal Article

    Van Cutsem, E.; Yaeger, R.; Delord, J. P.; Tabernero, J.; Siu, L. L.; Ducreux, M.; Siena, S.; Elez, E.; Kasper, S.; Zander, T.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Phase I study of entinostat, atezolizumab, carboplatin, and etoposide in previously untreated extensive-stage small cell lung cancer, ETCTN 10399
    Journal Article

    Gentzler, R. D.; Villaruz, L. C.; Rhee, J. C.; Horton, B.; Mock, J.; Hanley, M.; Kim, K.; Rudek, M. A.; Phelps, M. A.; Carducci, M. A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Is multifocality a predictor of poor outcome in childhood and adolescent papillary thyroid carcinoma?
    Journal Article

    Scholfield, D. W.; Lopez, J.; Eagan, A.; Antal, Z.; Tuttle, R. M.; Ghossein, R.; LaQuaglia, M.; Shaha, A. R.; Shah, J. P.; Wong, R. J.; more...
    Journal of Clinical Endocrinology and Metabolism (2023)

    Fulltext@MSK | Save

    • Oxford University Press – authorized name for: